
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Abbott Xience Pro S Coronary Stent (REF 1508275-23) is a drug-eluting coronary stent system supplied in a 2.75 mm x 23 mm configuration. It is part of Abbott's Xience family of everolimus-eluting coronary stents, designed for percutaneous coronary intervention procurement programs serving cardiac catheterization laboratories.
Key Features
- Drug-eluting platform: Everolimus-eluting coronary stent technology from the Xience family
- Stent dimensions: 2.75 mm nominal diameter x 23 mm length
- Delivery system: Rapid exchange balloon catheter delivery (consult IFU for working length and guide compatibility)
- Polymer coating: Fluoropolymer-based coating designed to control drug release
- Radiopaque markers: Catheter markers to assist fluoroscopic positioning
- Single-use, sterile: Provided sterile for single-patient use
Clinical Applications
- Coronary artery disease: Intended for use in percutaneous coronary intervention as described in the manufacturer's Instructions for Use
- Vessel sizing: 2.75 mm diameter suited to mid-range reference vessel diameters per IFU sizing matrix
- Lesion length: 23 mm length intended for medium-length target lesions
- Cath lab inventory: Suitable for interventional cardiology stocking and consignment programs
Product Information
- Brand: Abbott
- Product line: Xience Pro S
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: 1508275-23
- Diameter: 2.75 mm
- Length: 23 mm
- Drug: Everolimus (per Xience platform)
- Sterilization: Sterile, single-use
- Shelf life / storage: Not specified in the located sources
- Regulatory status: Not specified in the located sources; verify country-specific approval prior to procurement
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.